急诊止血术后非计划重返手术室的术中相关因素
该回顾性研究(2017—2022年)利用麻醉记录分析225例接受急诊止血手术的出血创伤患者,其中46例(20%)发生非计划重返手术室(uROR)。uROR组损伤严重度评分更高(30 vs 25,p=0.007),术中输注更多浓缩红细胞(11.5±10.6 vs 7.8±7.5,p=0.006)和血浆(9.6±8.3 vs 6.5±6.6,p=0.01),接受≥10 U浓缩红细胞的比例更高(48% vs 27%,p=0.006),损伤控制手术更常见(78% vs 45%,p<0.0001)。多因素回归显示,术中输注≥10 U浓缩红细胞(OR 4.3,95%CI 1.5-12.8,p=0.009)、晶体液(OR 1.0,95%CI 1.0-1.001,p=0.009)、INR(OR 7.6,95%CI 1.3-45.7,p=0.03)及损伤控制手术(OR 5.7,95%CI 1.7-19.1,p=0.005)与uROR独立相关。作者认为,对接受≥10 U输血的出血创伤患者,术中应注重限制晶体液并持续进行平衡复苏,尤其在损伤控制手术期间。
要点
- 出血创伤患者急诊止血术后uROR发生率为20%(46/225)。
- uROR组术中浓缩红细胞输注量更高(11.5±10.6 vs 7.8±7.5,p=0.006),接受≥10 U者比例更高(48% vs 27%,p=0.006)。
- 多因素回归中,术中≥10 U浓缩红细胞(OR 4.3,95%CI 1.5-12.8,p=0.009)、INR(OR 7.6,95%CI 1.3-45.7,p=0.03)、损伤控制手术(OR 5.7,95%CI 1.7-19.1,p=0.005)与uROR独立相关。
- 晶体液输注量在uROR组与对照组间无差异(3,552±2,279 mL vs 2,977±2,817 mL,p=0.20),但多因素回归中晶体液与uROR独立相关(OR 1.0,95%CI 1.0-1.001,p=0.009)。
- 作者认为,对接受≥10 U输血的出血创伤患者,术中应注重限制晶体液并持续平衡复苏,尤其在损伤控制手术期间。
适用人群与场景
- 接受急诊止血手术的出血创伤患者,纳入2017—2022年麻醉记录,共225例。
研究设计与关键结果
- 回顾性研究(2017—2022年)利用麻醉记录分析225例接受急诊止血手术的出血创伤患者,46例(20%)发生uROR,181例(80%)未发生。
- uROR组与对照组在人口学、致伤机制、入院生理指标或急诊至手术室时间方面无差异,但uROR组损伤严重度评分更高(30 vs 25,p=0.007)。
- 晶体液输注量(3,552±2,279 mL vs 2,977±2,817 mL,p=0.20)、全血(2.2±0.9 vs 2.0±0.5,p=0.20)、血小板(11.6±8.6 vs 9.2±9.0,p=0.14)两组无差异。
- uROR组浓缩红细胞输注量更多(11.5±10.6 vs 7.8±7.5,p=0.006),血浆更多(9.6±8.3 vs 6.5±6.6,p=0.01),接受≥10 U浓缩红细胞者比例更高(48% vs 27%,p=0.006)。
- 损伤控制手术在uROR组更常见(78% vs 45%,p<0.0001)。
- 多因素回归显示,术中≥10 U浓缩红细胞(OR 4.3,95%CI 1.5-12.8,p=0.009)、晶体液(OR 1.0,95%CI 1.0-1.001,p=0.009)、INR(OR 7.6,95%CI 1.3-45.7,p=0.03)、损伤控制手术(OR 5.7,95%CI 1.7-19.1,p=0.005)与uROR独立相关。
证据类型、等级与局限
- 证据类型:回顾性研究,治疗/管理类证据,Level IV。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对接受≥10 U输血的出血创伤患者行止血手术时,提供者必须高度关注限制晶体液并持续进行平衡复苏,尤其在损伤控制手术期间。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Unplanned return to the operating room (uROR) is associated with worse outcomes and increased mortality. Little is known regarding intraoperative factors associated with uROR after emergent surgery in trauma patients. The objective of this study was to identify intraoperative factors associated with uROR after emergent hemorrhage control procedures in bleeding trauma patients.
METHODS: We used anesthetic record of intraoperative management to perform a retrospective study (2017-2022) of bleeding trauma patients who were taken for an emergent hemorrhage control operation.
RESULTS: A total of 225 patients met the inclusion criteria, 46 (20%) had uROR, and 181 (80%) did not. While there was no difference in demographics, mechanism, admission physiology, or time from emergency department to operating room, the uROR patients had a higher Injury Severity Score (30 vs. 25, p = 0.007). While there was no difference in volume of crystalloid infused (3,552 ± 2,279 mL vs. 2,977 ± 2,817 mL, p = 0.20), whole blood (2.2 ± 0.9 vs. 2.0 ± 0.5, p = 0.20), or platelets (11.6 ± 8.6 vs. 9.2 ± 9.0, p = 0.14), the uROR group received more packed red blood cells (11.5 ± 10.6 vs. 7.8 ± 7.5, p = 0.006) and plasma (9.6 ± 8.3 vs. 6.5 ± 6.6, p = 0.01), and more uROR patients received ≥10 U of packed red blood cells (48% vs. 27%, p = 0.006). Damage-control surgery (DCS) was more common in uROR patients (78% vs. 45%, p < 0.0001). After logistic regression, ≥10 U of packed cells in the operating room (4.3 [1.5-12.8], p = 0.009), crystalloid (1.0 [1.0-1.001], p = 0.009), International Normalized Ratio (INR) (7.6 [1.3-45.7], p = 0.03), and DCS (5.7 [1.7-19.1], p = 0.005) were independently associated with uROR.
CONCLUSION: Massive transfusion, crystalloid resuscitation, persistent coagulopathy, and DCS are the most significant risk factors for uROR. During hemorrhage control surgery in bleeding trauma patients who receive ≥10 U of blood, providers must maintain a keen focus on minimizing crystalloid and ongoing balanced resuscitation, particularly during damage-control procedures.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level IV.
参考来源
- Wilson KM, Mery MW, Bengtson E, et al. Intraoperative factors associated with unplanned return to the operating room after emergent hemorrhage control surgery. J Trauma Acute Care Surg. 2024. PMID: 39325702. doi:10.1097/TA.0000000000004396
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。